We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Sandbridge Aquisition Corp | NYSE:OWLT | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.11 | 2.68% | 4.21 | 4.4823 | 4.11 | 4.18 | 10,019 | 21:00:22 |
From May 2023 to May 2024
By Dean Seal
Owlet shares are trading higher on Tuesday after the company got regulatory clearance for its BabySat medical pulse-oximetry device.
The stock was up 15% at 29 cents in early trading. Shares have nearly been halved since the start of the year and have fallen 87% over the past 12 months.
The infant health data company said Tuesday morning that the U.S. Food and Drug Administration granted clearance for BabySat, a device that uses pulse-oximetry technology to provide a real-time display of a baby's heart rate and oxygen saturation level and alert parents when those readings fall out of prescribed ranges.
BabySat is expected to be available in the U.S. later this year.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
June 20, 2023 10:36 ET (14:36 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Sandbridge Aquisition Chart |
1 Month Sandbridge Aquisition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
